Ushio Yuuka, Yoshikawa Hiroshi, Murase Tetsuya, Kataoka Tatsuo, Miyamoto Shohei, Maruko Kazunari, Okamoto Shoko, Shibata Yuuka, Toda Ryotaro, Kiuchi Yoshiaki, Matsuo Hiroaki
Department of Pharmaceutical Services, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-shi, Hiroshima, 734-8551, Japan.
Department of Ophthalmology and Visual Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
J Pharm Health Care Sci. 2023 Mar 1;9(1):8. doi: 10.1186/s40780-023-00276-z.
There is no unified view of the necessity of prophylactic antimicrobial agents in trabeculectomy. Preoperative prophylactic antimicrobial agent injection and cefazolin sodium (CEZ) for trabeculectomy were discontinued at the Hiroshima University Hospital. In this study, we evaluated whether discontinuation of preoperative administration of CEZ in ophthalmology affects the incidence of postoperative infections.
We retrospectively investigated patient background, concomitant medications, subconjunctival dexamethasone sodium phosphate (DEX) injection at the end of the surgery, and the incidence of infective endophthalmitis within 6 weeks after surgery in the CEZ and non-CEZ groups. We also performed propensity score matching for background matching. Statistical analysis was performed using the Mann-Whitney U-test and Fisher's exact test.
The incidence of postoperative endophthalmitis was not significantly different between 629 and 751 patients in the CEZ and no-CEZ groups, respectively (0 in the CEZ group and 2 in the no-CEZ group, P = 0.504). More patients in the CEZ group were taking diabetes drugs preoperatively (P = 0.028) and fewer patients were receiving subconjunctival DEX at the end of surgery (P < 0.001) than those in the non-CEZ group. Propensity scores were calculated using the risk factors for postoperative infection as covariates, and matching (580 patients in the CEZ group and 580 patients in the non-CEZ group) showed no significant difference in the incidence of postoperative endophthalmitis (P = 0.500).
There was no significant difference in the incidence of endophthalmitis after trabeculectomy between the CEZ and non-CEZ groups, suggesting a decreased need for CEZ injections before trabeculectomy.
小梁切除术中预防性使用抗菌药物的必要性尚无统一观点。广岛大学医院已停止在小梁切除术中术前预防性注射抗菌药物及使用头孢唑林钠(CEZ)。在本研究中,我们评估了眼科手术中停止术前使用CEZ是否会影响术后感染的发生率。
我们回顾性调查了CEZ组和非CEZ组患者的背景、伴随用药情况、手术结束时结膜下注射地塞米松磷酸钠(DEX)情况以及术后6周内感染性眼内炎的发生率。我们还进行了倾向得分匹配以进行背景匹配。使用Mann-Whitney U检验和Fisher精确检验进行统计分析。
CEZ组的629例患者和非CEZ组的751例患者术后眼内炎的发生率无显著差异(CEZ组为0例,非CEZ组为2例,P = 0.504)。与非CEZ组相比,CEZ组术前服用糖尿病药物的患者更多(P = 0.028),手术结束时接受结膜下DEX注射的患者更少(P < 0.001)。以术后感染的危险因素作为协变量计算倾向得分,匹配后(CEZ组580例患者和非CEZ组580例患者)术后眼内炎的发生率无显著差异(P = 0.500)。
CEZ组和非CEZ组小梁切除术后眼内炎的发生率无显著差异,提示小梁切除术前CEZ注射的必要性降低。